What is Haemonetics's book value per share?

Haemonetics (HAE) reported book value per share of $16.82 in Q1 2026.

How has Haemonetics's book value per share changed year-over-year?

Haemonetics's book value per share increased by 3.9% year-over-year, from $16.18 to $16.82.

What is the long-term trend for Haemonetics's book value per share?

Over 5 years (2021 to 2026), Haemonetics's book value per share has grown at a 3.3% compound annual growth rate (CAGR), from $14.26 to $16.82.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Haemonetics HAE Book value per share

Book value per share at other companies

AbbottABT

$29.80+6.7%

TFX

TeleflexTFX

$69.69-21.8%

Boston ScientificBSX

$17.30+16.3%

MedtronicMDT

$38.40+3.1%

LivaNovaLIVN

$21.65+13.9%

ICU MedicalICUI

$83.87+3.5%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

total stockholders equity/weighted shares diluted=$16.82

Based on the most recent quarter.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's book value per share?: Haemonetics (HAE) reported book value per share of $16.82 in Q1 2026.
How has Haemonetics's book value per share changed year-over-year?: Haemonetics's book value per share increased by 3.9% year-over-year, from $16.18 to $16.82.
What is the long-term trend for Haemonetics's book value per share?: Over 5 years (2021 to 2026), Haemonetics's book value per share has grown at a 3.3% compound annual growth rate (CAGR), from $14.26 to $16.82.
What does book value per share mean?: Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.